Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
David Gamm
Johns Hopkins University, Department: Ophthalmology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Opsis Therapeutics, LLC
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
An outside activity has a nexus with an individual's research activities if the outside activity arises from, relies upon or is related to the academic expertise that qualifies that individual to participate in federally funded research or human subjects research. The Institution has reasonably determined that the significant financial interest could directly and
significantly affect the design, conduct, or reporting of the PHS-funded research and so requires management.
Screening for Molecules that Promote Photoreceptor Synaptogenesis
NARRATIVE Based on transplantation experiments that have been performed to date, one of the major challenges to restoring vision to blind patients by transplanting stem cell-derived photoreceptor cells is the very low efficiency of donor cell integration and synapse formation within the recipient retina. In the spirit of NEI?s Audacious Goals program, designed ?to restore vision through regeneration of neurons and neural connections in the eye and visual system,? we propose to combine state-of-the-art stem cell methodologies with high content screening approaches to discover novel small molecules and molecular pathways that promote human photoreceptor axonal outgrowth and synapse formation. If successful, the discovery of such molecules and pathways would greatly aid in the development of viable approaches to restore vision to individuals suffering from photoreceptor damage and degeneration.
Filed on December 07, 2018.
Tell us what you know about David Gamm's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
David Gamm filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| David Gamm | University of Wisconsin Madison | Conflict of Interest | Opsis Therapeutics, LLC | $100,000 - $149,999 |
| David Gamm | Johns Hopkins University | Conflict of Interest | Opsis Therapeutics, LLC | $100,000 - $149,999 |
| David Gamm | University of Wisconsin Madison | Conflict of Interest | Opsis Therapeutics, LLC | $80,000 - $99,999 |
| David Gamm | Children's Hosp of Philadelphia | Conflict of Interest | Opsis Therapeutics, LLC | $60,000 - $79,999 |
| David Gamm | University of Wisconsin Madison | Conflict of Interest | Opsis Therapeutics, LLC | $60,000 - $79,999 |
| David Gamm | Johns Hopkins University | Conflict of Interest | Opsis Therapeutics, LLC | $60,000 - $79,999 |
| David Gamm | University of Wisconsin Madison | Conflict of Interest | Opsis Therapeutics, LLC | $0 - $4,999 |
| David Gamm | University of Wisconsin Madison | Conflict of Interest | Opsis Therapeutics, LLC | $0 - $4,999 |
| David Gamm | Johns Hopkins University | Conflict of Interest | Cellular Dynamics International, Inc. | Value cannot be readily determined |
| David Gamm | Children's Hosp of Philadelphia | Conflict of Interest | Cellular Dynamics International, Inc | Value cannot be readily determined |
| David Gamm | University of Wisconsin Madison | Conflict of Interest | Opsis Therapeutics, LLC | Value cannot be readily determined |
| David Gamm | Children's Hosp of Philadelphia | Conflict of Interest | Opsis Therapeutics, LLC | Value cannot be readily determined |
| David Gamm | Children's Hosp of Philadelphia | Conflict of Interest | Opsis Therapeutics, LLC | Value cannot be readily determined |
| David Gamm | Johns Hopkins University | Conflict of Interest | Opsis Therapeutics, LLC | Value cannot be readily determined |
| David Gamm | University of Wisconsin Madison | Conflict of Interest | Opsis Therapeutics, LLC | Value cannot be readily determined |
| David Gamm | University of Wisconsin Madison | Conflict of Interest | Cellular Dynamics International, Inc | Value cannot be readily determined |
| David Gamm | University of Wisconsin Madison | Conflict of Interest | Cellular Dynamics International, Inc | Value cannot be readily determined |
| David Gamm | University of Wisconsin Madison | Conflict of Interest | Opsis Therapeutics, LLC | Value cannot be readily determined |
| David Gamm | University of Wisconsin Madison | Conflict of Interest | Cellular Dynamics International, Inc | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.